INIS
diseases
100%
patients
100%
drugs
100%
risks
100%
arthritis
100%
fractures
100%
comparative evaluations
18%
hazards
18%
females
9%
clinical trials
9%
hands
9%
design
9%
losses
9%
populations
9%
bones
9%
incidents
9%
denmark
9%
vertebrae
9%
Keyphrases
Rheumatoid Arthritis
100%
Biological Disease-modifying Antirheumatic Drugs (bDMARDs)
100%
Osteoporotic Fracture Risk
100%
Osteoporotic Fractures
45%
Nave
27%
Drug Users
27%
Beneficial Effects
18%
Risk Reduction
18%
Biological Treatment
18%
Confidence Interval
9%
Clinical Trials
9%
Fracture Site
9%
Population-based
9%
Incidence Rate
9%
Denmark
9%
Propensity Score
9%
Non-associated
9%
Hazard Ratio
9%
Cox Proportional Hazards Model
9%
Fracture Risk
9%
Forearm
9%
Vertebrae
9%
Humerus
9%
Bone Loss
9%
Health Registries
9%
Risk Estimation
9%
New-user Design
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Fragility Fracture
100%
Rheumatoid Arthritis
100%
Disease Modifying Antirheumatic Drug
100%
Inflammatory Arthritis
100%
Clinical Trial
9%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Clinical Trial
100%
Osteolysis
100%
Population Health
100%
Immunology and Microbiology
Inflammatory Arthritis
100%
Disease-Modifying Antirheumatic Drug
100%
Osteolysis
9%
Hip
9%
Vertebra
9%
Population Health
9%